20/20 Biolabs, Inc. (AIDX)
Nasdaq: AIDX · Services-Testing Laboratories · Rockville, MD · filing with the SEC since 2002
Who runs 20/20 Biolabs, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Cohen Jonathan M
Chief Executive Officer. First filing Feb 2026, latest Mar 4, 2026, 0 filings in all.
Officers reporting now
5
of 10 people with a filing in the last fifteen months
Directors reporting now
5
10 people on the record since 2026
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Bergman Alan B. | Chief Financial Officer | Feb 2026 | Apr 6, 2026 | none |
| Zhou Jiming | Chief Operating Officer | Feb 2026 | Apr 6, 2026 | none |
| Cohen Jonathan M | Chief Executive Officer | Feb 2026 | Mar 4, 2026 | none |
| Baker Ron | Chief Business Officer | Feb 2026 | Feb 17, 2026 | none |
| Lebowitz Michael Saul | Chief Scientific Officer | Feb 2026 | Feb 17, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Cohen Richard M | director | Feb 2026 | Feb 23, 2026 | none |
| Compton John G. | director | Feb 2026 | Feb 23, 2026 | none |
| Rollins John Woodson | director | Feb 2026 | Feb 23, 2026 | none |
| Ross Michael A. | director | Feb 2026 | Feb 23, 2026 | none |
| Reddy Prasanth | director | Feb 2026 | Feb 17, 2026 | none |
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.